PROFILE VIEW

Ananta Medicare

Manufacturer

ENDLESS CARE ABOUT YOUR HEALTH is the main priority of group of companies «Ananta Medicare». «Ananta Medicare» aims to protect and preserve the most important human values - good health and quality of life. Group of companies «Ananta Medicare» specializes in manufacturing and marketing of high-quality generic medicines as well as food supplements and cosmetic products with natural components. «Ananta Medicare» has subsidiaries in Europe (United Kingdom), Asia (India) and the CIS (Ukraine). For more than 17-years history of the corporate group «Ananta Medicare», the production of the company has earned confidence of patients and doctors from different countries. The company's success is the result of tireless work, devotion and high professionalism of our employees. Nowadays, the purpose of the company is an expansion of sales markets in different regions of the world. Within the framework of the development strategy, «Ananta Medicare» enhances production capacity, improves product portfolio, forms the professional team and takes an active part in research programs. MISSION Our mission is to provide high-quality medicines and remedies at affordable prices in the interest of patients' health and to provide medicinal and pharmaceutical experts with high-quality medical products in accordance with current health standards. VALUES The values that we share are the key to the success of «Ananta Medicare»: QUALITY EFFICIENCY CUSTOMER FOCUS PARTNERSHIP FIRMNESS OF PURPOSE INNOVATION DYNAMIC DEVELOPMENT CONFIDENCE RESPONSIBILITY COHESION VISION «Ananta Medicare» vision: a constant care about the health and quality of human life by improving general healthcare culture and close collaboration with specialists in the fields of medicine and pharmacy. Driving force of development «Ananta Medicare» is the principle «The future starts today!». Therefore, the company’s nearest plans are building new production capacities, expanding the range of products and pharmaco-therapeutic fields, research and development of new medicinal products and representation of the company's products in the global market. MANUFACURING Medicines and natural remedies are made in Italy, India, Japan and Ukraine at its own plants and on contractual agreements. The manufacturing process complies with international GMP standards and meets the requirements of quality production standards. Own manufacturing All products of «Ananta Medicare» are manufactured at the modern pharmaceutical plants. In 2015 there was a launch of a new plant of «Ananta Medicare», specializing in the production of food supplements and natural cosmetic products. Products are manufactured in the form of tablets, capsules, syrups, lozenges, creams, ointments and other forms. The construction of two plants for the manufacturing of medicinal products is at the final stage. The total area of these plants is about 30 thousand square meters. In 2017 the company is about to open a new plant to manufacture cephalosporin antibiotics (oral and parenteral forms) and a plant to manufacture non-sterile medicinal products of different groups. Manufacturing and quality control systems of these plants have been designed in compliance with GMP requirements and will be certified by authorized bodies PIC/S– MHRA, FDA etc. «Ananta Medicare» produces medicinal products under its own brands at the following partner plants: Flamingo Pharmaceuticals Ltd. (India) • Eurolife Healthcare Pvt. Ltd. (India) • Marksans Pharma Ltd. (India) Hetero Labs Limited (India) Swiss Parenterals Pvt. Ltd.(India) Kopran Ltd. (India) Venus Remedies Limited (India) Indoco Remedies Ltd. (India) Bruschettini s.r.l. (Italy) • Laboratorio Italiano Biochimico Farmaceutico Lisapharma S.P.A. (Italy) • Labomar S.r.L. (Italy) and other enterprises (Japan, India, Ukraine). PRODUCT PORTFOLIO The product portfolio of prescribed and non-prescribed products of «Ananta Medicare» corresponds to modern trends in medicine and it is formed in strict compliance with the company's development strategy. The product portfolio includes a wide range of medicines and natural remedies manufactured in different dosage forms (tablets, capsules, lozenges, syrups, sprays, gels, parenteral dosage forms (solutions, powders for injection / infusion) that allow to prevent and to treat various diseases, such as cardiovascular, endocrine, neurological, gastrointestinal, allergic, dermatological and infectious diseases as well as diseases of the genitourinary system. The company's marketing strategy and multi-level quality control of products are our constant priority and they are aimed to ensure that every product meets the most stringent international standards. QUALITY CONTROL «Uncompromising quality» is a basis of philosophy of «Ananta Medicare», since high quality is a predictable efficacy and guarantee safety.

Contact Information

0671896212

Mallard House, Townmead Rd, Fulham, London SW6 2BF, UK

Products

- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Product type Brand name Content Dosage form Medical Classification

Finished Product

TIGOFAST  Fexofenadine 180 mg Tablet, film coated 30 BLPK Dermatology, Respiratory System,

Finished Product

METRESSA Metronidazole 0.5 % Solution 100 mL CTR Antimicrobial agent,

Finished Product

AZICLAR Clarithromycin 250 mg Tablet 10 BLPK Antimicrobial agent,

Finished Product

GLINOVA Glimepiride 4 mg Tablet 30 BLPK Endocrine System,

Finished Product

MAGLIFORT 1000 Metformin 1000 mg Tablet 30 BLPK Endocrine System,

Finished Product

CARDIPRIL 10 Ramipril 10 mg Capsule 30 BLPK Cardiovascular System,

Finished Product

TORICARD 5 Torasemide 5 mg Tablet 30 BLPK Cardiovascular System,

Finished Product

FLUCONAZOL Fluconazole 200 mg Injection, solution 100 mL CTR Dermatology,

Finished Product

ITRUNGAR Itraconazole 100 mg Capsule 15 BLPK Dermatology,

Finished Product

ZOLEUM Zoledronic acid 4 mg Injection 5 mL VIAL Oncology,

Finished Product

PLATICARB 450 Carboplatin 10 mg Injection 45 mL VIAL Oncology,

Finished Product

PLATISAN Cisplatin 1 mg Injection 50 mL VIAL Oncology,

Finished Product

LOCID 20 Omeprazole 20 mg Capsule 10 BLPK Digestive System,

Finished Product

PANOCID 40 Pantoprazole 40 mg Tablet 10 BLPK Digestive System,

Finished Product

FLAMOGREL 75 Clopidogrel 75 mg Tablet 10 BLPK Cardiovascular System,

Finished Product

GRIPPFLU Paracetamol 500 mg Caffeine 30 mg Phenylephrine 10 mg Dexchlorpheniramine 2 mg Tablet 200 BLPK Respiratory System,

Finished Product

SILDENAFIL ANANTA 50 Sildenafil 50 mg Tablet 4 BLPK Urogenital System,

Finished Product

ROMESTIN 20  Rosuvastatin 20 mg Tablet 30 BLPK Cardiovascular System,

Finished Product

SIMVASTATIN 40 Simvastatin 40 mg Tablet 28 BLPK Cardiovascular System,

Finished Product

MEFENAMIC ACID 250 Mefenamic acid 250 mg Capsule 20 BLPK Musculoskeletal System,

Finished Product

MEFENAMIC ACID 500 Mefenamic acid 500 mg Capsule 20 BLPK Musculoskeletal System,

Finished Product

ANAPIRON Paracetamol 10 mg Injection, solution 100 mL CTR Respiratory System,

Finished Product

PACLINOR 100 Paclitaxel 6 mg Injection, solution 16 mL VIAL Oncology,

Finished Product

SILDENAFIL ANANTA 100 Sildenafil 100 mg Tablet 4 BLPK Urogenital System,

Finished Product

PHLAMIFIKS 200 Cefixime 200 mg Capsule 10 BLPK Antimicrobial agent,